Utilities Registry
Submit a utility to the registry.
Title | Year(s) of data collection | Valuation Method | Country | Condition |
---|---|---|---|---|
Selection of general population health health state utilities | 2021 | SF-6Dv2 | China | General population health, Haemophilia |
|
||||
Title
Selection of mental health health state utilities
|
Year(s) of data collection
2017
|
Valuation Method
EQ-5D, SF-6D
|
Country
United States of America
|
Condition
Depression
|
|
||||
Title
Selection of COVID-19 health state utilities
|
Year(s) of data collection
2021
|
Valuation Method
SF-6D
|
Country
United Kingdom of Great Britain and Northern Ireland
|
Condition
COVID-19
|
|
||||
Title
Selection of general population health health state utilities
|
Year(s) of data collection
2019
|
Valuation Method
SF-6D
|
Country
Ireland
|
Condition
General population health
|
|
||||
Title
Selection of neurological disease health state utilities
|
Year(s) of data collection
2009 - 2011
|
Valuation Method
SF-6D
|
Country
Finland
|
Condition
Cognitive decline
|
|
||||
Title
Selection of autoimmune disease health state utilities
|
Year(s) of data collection
2016 - 2020
|
Valuation Method
SF-6D
|
Country
United States of America
|
Condition
Calcinosis in systemic sclerosis
|
|
||||
Title
Selection of general population health health state utilities
|
Year(s) of data collection
2017
|
Valuation Method
EQ-5D-5L, TTO
|
Country
Sweden
|
Condition
General population health
|
|
||||
Title
Selection of general population health health state utilities
|
Year(s) of data collection
2019
|
Valuation Method
EQ-5D-5L, SF-6Dv2
|
Country
China
|
Condition
General population health
|
|
||||
Title
Selection of orthopedic and musculoskeletal health state utilities
|
Year(s) of data collection
2014 - 2016
|
Valuation Method
EQ-5D-5L, SF-6D
|
Country
Netherlands
|
Condition
Fracture
|
|
||||
Title
Selection of autoimmune disease health state utilities
|
Year(s) of data collection
2021
|
Valuation Method
EQ-5D-5L, HUI3
|
Country
Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America
|
Condition
Myasthenia gravis
|
|